04 September 2017

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

04 September 2017 | n=22

  1. Weinstein M, Yang OO, Cohen AC.
    Were we prepared for PrEP? five years of implementation.
    AIDS 2017.

  2. Medland NA, Nicholson S, Chow EPF, Read THR, et al.
    Time from HIV infection to virological suppression: dramatic fall from 2007-2016.
    AIDS 2017.

  3. Winter JR, Stagg HR, Smith CJ, Brown AE, et al.
    Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV from 2000 to 2014.
    AIDS 2017.

  4. Orlova-Fink N, Chowdhury FZ, Xiaoming S, Harrington S, et al.
    Preferential susceptibility of Th9 and Th2 CD4 T cells to X4-tropic HIV-1 infection.
    AIDS 2017.

  5. Rubin LH, Cook JA, Springer G, Weber KM, et al.
    Perceived and post-traumatic stress are associated with decreased learning, memory, and fluency in HIV-infected women.
    AIDS 2017.

  6. Boccara F, Ghislain M, Meyer L, Goujard C, et al.
    Impact of protease inhibitors on circulating PCSK9 levels in HIV-infected antiretroviral-naive patients from the ANRS COPANA cohort.
    AIDS 2017.

  7. Thiebaut R, Hue S, Le Marec F, Lelievre JD, et al.
    Serum ST2 level is an independent predictor of all-cause mortality in HIV-infected patients. Aquitaine Cohort, France.
    AIDS 2017.

  8. Flores Herrera MF, Dauby N.
    Eye compartmentalization of HIV replication and cataract risk in HIV-infected patients: is there a link?
    AIDS 2017;31:2024-2025.

  9. Klatt NR, Hunt PW.
    MicroRNAs: novel tools to block gut inflammation in HIV?
    AIDS 2017;31:2017-2018.

  10. Alvarez-Del Arco D, Fakoya I, Thomadakis C, Pantazis N, et al.
    High levels of postmigration HIV acquisition within nine European countries.
    AIDS 2017;31:1979-1988.

  11. Ronit A, Kristensen T, Klitbo DM, Gelpi M, et al.
    Incidental lung cancers and positive computed tomography images in people living with HIV.
    AIDS 2017;31:1973-1977.

  12. Yildiz Sevgi D, Gunduz A, Altuntas Aydin O, Mete B, et al.
    Adherence to Antiretroviral Therapy in Turkey: Results from the ACTHIV-IST Study Group.
    AIDS Res Hum Retroviruses 2017.

  13. Loeb Stanga L, Packel L, Martz T, Lemp G, et al.
    The California HIV/AIDS Research Program: History, Impact, and HIV Cure Initiative.
    AIDS Res Hum Retroviruses 2017.

  14. Hegedus A, Kavanagh Williamson M, Khan MB, Dias Zeidler J, et al.
    Evidence for altered glutamine metabolism in HIV-1 infected primary human CD4+ T cells.
    AIDS Res Hum Retroviruses 2017.

  15. Zhang M, Xin R, Chang W.
    A novel recombinant form of HIV-1 CRF01_AE/CRF07_BC identified by near full-length genome in Shaanxi, China.
    AIDS Res Hum Retroviruses 2017.

  16. Walensky RP, Borre ED, Bekker LG, Hyle EP, et al.
    Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid.
    Ann Intern Med 2017.

  17. Markowitz M, Grossman H, Anderson PL, Grant R, et al.
    Newly Acquired Infection with Multi-Drug Resistant HIV-1 in a Patient Adherent to Pre-Exposure Prophylaxis.
    J Acquir Immune Defic Syndr 2017.

  18. Goldstone RN, Hasan SR, Goldstone SE.
    Radiofrequency ablation therapy for anal intraepithelial neoplasia: results from a single-center prospective pilot study in HIV+ participants.
    J Acquir Immune Defic Syndr 2017.

  19. Clutter DS, Zhou S, Varghese V, Rhee SY, et al.
    Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing.
    J Infect Dis 2017;216:387-391.

  20. van Laarhoven A, Dian S, Ganiem AR, van Crevel R, et al.
    Reply to Neeradi et al and Dhawan and Sankhyan.
    J Infect Dis 2017;216:395-396.

  21. Dehghani-Dehej F, Sarvari J, Esghaei M, Hosseini SY, et al.
    Presence of Different Hepatitis C Virus Genotypes in Plasma and Peripheral Blood Mononuclear Cell Samples of Iranian Patients with HIV Infection.
    J Med Virol 2017.

  22. Green A.
    President of Zambia declares HIV testing mandatory.
    Lancet 2017.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

18 September 2017

11 September 2017

04 September 2017

28 August 2017

21 August 2017


04 September 2017

Multidisciplinary Journal Club

  1. Schachter J, Ribas A, Long GV, Arance A, et al.
    Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).
    Lancet. 2017 Aug 16. pii: S0140-6736(17)31601.

  2. Mamounas EP, Kuehn T, Rutgers EJT, von Minckwitz G, et al.
    Current approach of the axilla in patients with early-stage breast cancer.
    Lancet. 2017 Aug 14. pii: S0140-6736(17)31451.

  3. van Es N, Le Gal G, Otten HM, Robin P, et al.
    Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient Data.
    Ann Intern Med. 2017 Aug 22. doi: 10.7326/M17-0868.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016